About the Global Influenza Programme  Help  Contact   
 Home page  Search  Titles  Subjects  Target Group  Organizations  Type of document  Keywords  Hide the page description box
On this page the documents are listed according to their type. Select the bookshelf icon of a certain type to view the concerned documents. Clicking on the bookshelf icon again will close the documents list and return to the previous page. Publications are available in PDF , PPT or DOC format. Click on the corresponding icon to open the publication.
4 documents on 1 page in this set   
close this section of the libraryInformation Note
open this document and view its contentView the PDF document
Date of last change: 6 May 2009
Type of document: Information Note;  Pages: 1;  Time allotted: N.A.
Description: Considering the potential impact of emerging influenza A(H1N1) virus infection, this informational note informs HIV/AIDS programmes and services to be aware of relevant risks and have plans for prevention and treatment.
open this document and view its contentGo to website
Date of last change: 16 July 2009
Type of document: Information Note;  Pages: 1;  Time allotted: N.A.
Description: This note provides information on approapriate specimen storage and transport of influenza specimen
open this document and view its contentView the PDF document
Date of last change: 12 November 2009
Type of document: Information Note;  Pages: 2;  Time allotted: N.A.
Description: A substantial number of deaths have occurred in patients with chronic respiratory conditions, raising concern about the possible impact of influenza on patients with active tuberculosis. This note is intended to sensitize tuberculosis programme managers to possible challenges and synergies in the efforts to control the two conditions.
open this document and view its contentView the PDF document
Date of last change: 18 December 2009
Type of document: Information Note;  Pages: 3;  Time allotted: N.A.
Description: The Global Advisory Committe on Vaccine Safety (GACVS) reviewed the safety of pandemic (H1N1) 2009 vaccines currently in use. To date, the safety data are reassuring and no unexpected safety concerns have been identified. Ongoing vaccine safety monitoring (pharmacovigilance) is critical, including regular information sharing with WHO by national regulatory and health authorities.
SubjectsH1N1; Vaccines